Companies: 10,795·Total market cap: $144.5T
Revolution Medicines, Inc.

Revolution Medicines, Inc.

RVMDNASDAQHealthcare● Active
$149.23
$-6.46(-4.15%)
Market Cap$31.7B
P/E Ratio
52W High$166.5
52W Low$34
Overview

Revolution Medicines, Inc. (RVMD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RVMD · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-7.11rvmd eps ttm · rvmd earnings per shareEarnings history
PE Ratio (TTM)rvmd pe ratio ttm · rvmd price to earningsPE Ratio deep dive
Revenue (TTM)0.00rvmd revenue ttm · rvmd annual revenueFull revenue history
Dividend YieldNo Dividenddoes rvmd pay dividends · rvmd dividend yieldDividend history
Shares Outstanding190.1Mrvmd shares outstanding · rvmd floatShares outstanding history
Next EarningsAug 5, 2026Est.rvmd earnings date · rvmd next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
revolution medicines, inc. revenue · rvmd revenue 2025
FY 2025Net Income-$1.13B▼ 88.52% YoY
202320242025
revolution medicines, inc. net income · rvmd profit 2025
FY 2025EPS$-5.95▼ 66.20% YoY
202320242025
rvmd eps · revolution medicines, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$1.37BEPS: $-7.11View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy22 analystsis rvmd a buy · rvmd analyst rating
Strong Buy
1
Buy
20
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$73.00Low
$149.23Current
$165.33Avg Target10.79% upside
$205.00High
rvmd price target · rvmd 12 month forecast

Total: 22 · Buy rate: 95.5%

The RVMD analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $165.33, representing +10.79% upside from the current price of $149.23.

Stock Performance

Full History
1D-4.15%
1W-1.54%
1M+5.23%
3M+51.66%
YTD+87.36%
1Y+267.74%
5Y+362.16%

About Revolution Medicines, Inc.

CEOMark A. Goldsmith
IPO DateFeb 13, 2020
Employees616
CountryUS
Websiterevmed.com

Revolution Medicines, Inc. a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inh…

what is revolution medicines, inc. · rvmd stock overview · revolution medicines, inc. company profile · who is revolution medicines, inc. ceo · rvmd NASDAQ · revolution medicines, inc. headquarters · revolution medicines, inc. business segments

About Stock Overview & Key Data

Revolution Medicines, Inc. (RVMD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 13, 2020. As of the latest trading session, RVMD stock price is $149.23, with a market capitalization of $31.7B. The stock has returned +267.74% over the past 12 months and +87.36% year-to-date.

According to 22 Wall Street analysts, the consensus rating for Revolution Medicines, Inc. stock is Buy, with an average 12-month price target of $165.33. In fiscal year 2025, Revolution Medicines, Inc. reported revenue of — and net income of -$1.1B. For detailed data — including Revolution Medicines, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Revolution Medicines, Inc. (RVMD) stock price is $149.23. The stock is traded on NASDAQ under the ticker symbol RVMD. The 52-week range is $34.00 – $166.50.

RVMD stock priceRVMD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice